High level transient expression of the murine coronavirus haemagglutinin-esterase

References

1. Barthold S. W., Smith A. L. 1989; Virus strain specificity of challenge immunity to coronavirus. Archives of Virology 104:187–196
   [Google Scholar]
2. Cohen J. A., Osterbaan R. A., Berends F. 1967; Organo-phosphorous compounds. Methods in Enzymology 11:686–702
   [Google Scholar]
3. Deregt D., Babuik L. A. 1987; Monoclonal antibodies to bovine corona virus: characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins. Virology 164:410–420
   [Google Scholar]
4. Devereux J., Haeberli P., Smithies O. 1984; A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research 12:387–397
   [Google Scholar]
5. Fuerst T. R., Niles E. G., Studier F. W., Moss B. 1986; Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes T7 RNA polymerase. Proceedings of the National Academy of Sciences, U.S.A 83:8122–8126
   [Google Scholar]
6. Fuerst T. R., Earl P. L., Moss B. 1987; Use of hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Molecular and Cellular Biology 7:2538–2544
   [Google Scholar]
7. Gubler U., Hoffman B. J. 1983; A simple and very efficient method for generating cDNA libraries. Gene 25:263–269
   [Google Scholar]
8. Herrler G., Rott R., Klenk H.-D., Muller H.-P., Shukla A. K., Schauer R. 1985; The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO Journal 4:1503–1506
   [Google Scholar]
9. Herrler G., Dürkop I., Becht H., Klenk H.-D. 1988a; The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor. Journal of General Virology 69:839–846
   [Google Scholar]
10. Herrler G., Multhaup G., Beyreuther K., Klenk H.-D. 1988b; Serine 71 of the glycoprotein HEF is located at the active site of the acetylesterase of influenza C virus. Archives of Virology 102:269–274
    [Google Scholar]
11. Ichihashi Y., Dales S. 1971; Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Virology 46:533–543
    [Google Scholar]
12. Kienzle T. E., Abraham S., Hogue B. G., Brian D. A. 1990; Structure and orientation of expressed bovine coronavirus hemagglutinin-esterase protein. Journal of Virology 64:1834–1838
    [Google Scholar]
13. King B., Potts B. J., Brian D. A. 1985; Bovine coronavirus haemagglutinin protein. Virus Research 2:53–59
    [Google Scholar]
14. Kumanishi T. 1967; Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells. Japanese Journal of Experimental Medicine 37:461–474
    [Google Scholar]
15. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
16. Lamontagne L., Decarie D., Dupuy J. M. 1989; Host cell resistance to mouse hepatitis virus type 3 is expressed in vitro in macrophages and lymphocytes. Viral Immunology 2:37–45
    [Google Scholar]
17. Luytjes W., Bredenbeek P. J., Noten A. F. H., Horzinek M. C., Spaan W. J. M. 1988; Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology 166:415–422
    [Google Scholar]
18. Mackett M., Smith G. L., Moss B. 1985; The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: A Practical Approach pp 191–211 Edited by Glover D. M. Oxford: IRL Press;
    [Google Scholar]
19. Pachuk C. J., Bredenbeek P. J., Zoltick P. W., Spaan W. J. M., Weiss S. R. 1989; Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus strain A59. Virology 171:141–148
    [Google Scholar]
20. Parker M. D., Cox G. J., Deregt D., Fitzpatrick D. R., Babiuk L.A. 1989; Cloning and in vitro expression of the gene for the E3 haemagglutinin glycoprotein of bovine coronavirus. Journal of General Virology 70:155–164
    [Google Scholar]
21. Perlman S., Jacobsen G., Olson A. L., Afifi A. 1990; Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology 175:418–426
    [Google Scholar]
22. Rogers G. N., Herrler G., Paulson J. C., Klenk H.-D. 1986; Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. Journal of Biological Chemistry 261:5947–5951
    [Google Scholar]
23. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd. edn New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
24. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A 74:5463–5467
    [Google Scholar]
25. Schwarz B., Routledge E., Siddell S. G. 1990; Murine coronavirus non-structural protein ns2 is not essential for virus replication in transformed cells. Journal of Virology 64:4784–4791
    [Google Scholar]
26. Shieh C.-K., Lee H.-J., Yokomori K., La Monica N., Makino S., Lai M. M. C. 1989; Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. Journal of Virology 63:3729–3736
    [Google Scholar]
27. Siddell S. G. 1982; Coronavirus JHM: tryptic peptide fingerprinting of virion proteins and intracellular polypeptides. Journal of General Virology 62:259–269
    [Google Scholar]
28. Siddell S. G., Wege H., Barthel A., Ter Meulen V. 1980; Coronavirus JHM: cell-free synthesis of structural protein p60. Journal of Virology 33:10–17
    [Google Scholar]
29. Spaan W. J. M., Cavanagh D., Horzinek M. C. 1988; Coronaviruses: structure and genome expression. Journal of General Virology 69:2939–2952
    [Google Scholar]
30. St Aden R. 1982; Automation of the computer handling of gel reading data produced by the shotgun method of DNA sequencing. Nucleic Acids Research 10:4731–4751
    [Google Scholar]
31. Sugiyama K., Amano Y. 1980; Haemagglutination and structural polypeptides of a new coronavirus associated with diarrhea in infant mice. Archives of Virology 66:95–105
    [Google Scholar]
32. Sugiyama K., Amano Y. 1981; Morphological and biological properties of a new coronavirus associated with diarrhea in infant mice. Archives of Virology 67:241–251
    [Google Scholar]
33. Taguchi F., Massa P. T., Ter Meulen V. 1986; Characterization of a variant virus isolated from neural cell culture after infection of mouse coronavirus JHMV. Virology 155:267–270
    [Google Scholar]
34. Vlasak R., Krystal M., Nacht M., Palese P. 1987; The influenza C virus glycoprotein (HE) exhibits receptor binding (hemagglutinin) and receptor destroying (esterase) activities. Virology 160:419–425
    [Google Scholar]
35. Vlasak R., Luytjes W., Spaan W., Palese P. 1988a; Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proceedings of the National Academy of Sciences, U.S.A 85:4526–4529
    [Google Scholar]
36. Vlasak R., Luytjes W., Leider J., Spaan W., Palese P. 1988b; The E3 protein of bovine coronavirus is a receptor destroying enzyme with acetylesterase activity. Journal of Virology 62:4686–4690
    [Google Scholar]
37. Vlasak R., Muster T., Lauro A. M., Powers J. C., Palese P. 1989; Influenza C virus esterase: analysis of catalytic site, inhibition and possible function. Journal of Virology 63:2056–2062
    [Google Scholar]
38. Walker D. P., Cleator G. M. 1980; Haemagglutination by mouse hepatitis virus type 3. Annals of Virology 131:517E–520
    [Google Scholar]
39. Wege H., Wege H., Nagashima K., Ter Meulen V. 1979; Structural polypeptides of the murine coronavirus JHM. Journal of General Virology 42:37–47
    [Google Scholar]
40. Wege H., Siddell S. G., Ter Meulen V. 1982; The biology and pathogenesis of coronaviruses. Current Topics in Microbiology and Immunology 99:165–200
    [Google Scholar]
41. Wege H., Dörries R., Wege H. 1984; Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2). Journal of General Virology 65:1931–1942
    [Google Scholar]
42. Wege H., Winter J., Massa P., Dörries R., Ter Meulen V. 1987; Coronavirus-induced demyelinating disease: specific domains on the E2 protein are associated with neurovirulence. Advances in Expermental Medicine and Biology 218:307–320
    [Google Scholar]
43. Weiland E., Mussgay M., Weiland F. 1978; Non-producer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma. Journal of Experimental Medicine 148:408–423
    [Google Scholar]
44. Woods D. 1984; Oligonucleotide screening of CDNA libraries. Focus 6:1–3
    [Google Scholar]
45. Yokomori K., La Monica N., Makino S., Shieh C.-K., Lai M. M. C. 1989; Biosynthesis, structure, and biological activities of envelope protein gp65 of murine coronavirus. Virology 173:683–691
    [Google Scholar]